Which of the following anti neoplastic drug causes hepatotoxicity:
**Question:** Which of the following anti-neoplastic drugs causes hepatotoxicity:
A. Cisplatin
B. Cyclophosphamide
C. Paclitaxel
D. 5-Fluorouracil
**Core Concept:**
Hepatotoxicity is a side effect observed in patients treated with certain anti-neoplastic drugs, which are medications used to treat cancer. These drugs may cause liver damage due to their direct or indirect effects on hepatocytes (liver cells), leading to liver dysfunction and potential liver failure. Understanding potential hepatotoxicity associated with various drugs is crucial for safe and effective clinical practice.
**Why the Correct Answer is Right:**
Among the given options, the drug that is known to cause hepatotoxicity is **D. 5-Fluorouracil**. 5-Fluorouracil (5-FU) is a chemotherapeutic agent used to treat various types of cancer, particularly gastrointestinal malignancies. Hepatotoxicity is a recognized side effect of 5-FU therapy, occurring due to its direct cytotoxic effects on hepatocytes, which leads to liver dysfunction and potential liver failure.
**Why Each Wrong Option is Incorrect:**
1. **A. Cisplatin**: Cisplatin is an effective chemotherapeutic agent used to treat several types of cancer, including testicular, ovarian, and lung cancers. While cisplatin can cause nephrotoxicity (kidney damage), it is less commonly associated with hepatotoxicity compared to 5-FU.
2. **B. Cyclophosphamide**: Cyclophosphamide is a cytotoxic agent used in the treatment of various types of cancer. Hepatotoxicity is a known side effect of cyclophosphamide therapy, similar to 5-FU.
3. **C. Paclitaxel**: Paclitaxel is an anticancer medication primarily used in the treatment of breast, ovarian, and lung cancers. While hepatotoxicity is not as common as nephrotoxicity, it can occur as a side effect of paclitaxel therapy.
**Clinical Pearl:** It is essential for healthcare professionals to be aware of potential side effects associated with various anti-neoplastic drugs, including hepatotoxicity, to ensure appropriate monitoring and management of patients receiving these treatments, minimizing complications and optimizing treatment outcomes.